SCHEMBL4555970

SCHEMBL4555970

O=S(=O)(c1cccc(Cl)c1)N1CCCCCC1

nearest known ligand 0.97

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.97
▸ MEN1 O00255 3/20 0.97
▸ KMT2A Q03164 3/20 0.97
▸ SMN1; SMN2 Q16637 3/20 0.67
▸ TSHR P16473 5/20 0.66
▸ LMNA P02545 5/20 0.66
▸ NPSR1 Q6W5P4 3/20 0.66
▸ THRB P10828 1/20 0.66
▸ HTT P42858 3/20 0.59
▸ GAA P10253 1/20 0.59
▸ KDM4E B2RXH2 1/20 0.58
▸ POLB P06746 1/20 0.58
▸ ALOX15 P16050 1/20 0.58
▸ L3MBTL1 Q9Y468 1/20 0.58
▸ USP2 O75604 1/20 0.58
▸ MAPT P10636 3/20 0.58
▸ IL1RN P18510 1/20 0.58
▸ MITF O75030 1/20 0.57
▸ MCOLN3 Q8TDD5 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31684032 1.00 ALDH1A1 (0.97) ALDH1A1MEN1KMT2ASMN1; SMN2TSHR
SCHEMBL15010078 0.98 ALDH1A1 (1.00) ALDH1A1MEN1KMT2ASMN1; SMN2TSHR
SCHEMBL10726996 0.91 ALDH1A1 (0.86) ALDH1A1MEN1KMT2ASMN1; SMN2TSHR
SCHEMBL27974975 0.85 ALDH1A1 (0.76) ALDH1A1MEN1KMT2ASMN1; SMN2TSHR
SCHEMBL848429 0.83 KMT2A (0.73) ALDH1A1MEN1KMT2ASMN1; SMN2TSHR
SCHEMBL654409 0.83 MEN1 (0.73) ALDH1A1MEN1KMT2ATHRBHTT
SCHEMBL12674581 0.83 ALDH1A1 (0.72) ALDH1A1MEN1KMT2ASMN1; SMN2TSHR
SCHEMBL12674480 0.81 ALDH1A1 (0.74) ALDH1A1MEN1KMT2ASMN1; SMN2TSHR
SCHEMBL18948489 0.80 ALDH1A1 (0.63) ALDH1A1MEN1KMT2ASMN1; SMN2TSHR
SCHEMBL2960456 0.80 MEN1 (0.68) ALDH1A1MEN1KMT2ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2134714-A1 TRICYCLIC ISOQUINOLINE DERIVATIVES FOR TREATMENT OF OBESITY Biovitrum AB (publ) (SE) 2009-12-23 — — EP disclosed
WO-2008110598-A1 TRICYCLIC ISOQUINOLINE DERIVATIVES FOR TREATMENT OF OBESITY BIOVITRUM AB (PUBL) (SE) 2008-09-18 — — WO disclosed
Send feedback